CONTEXT: Vitamin D metabolism genes have been associated with type 1 diabetes (T1D) risk; however, these genes have not been investigated for association with the preclinical phase of T1D, islet autoimmunity (IA). Studies of vitamin D metabolism genes may elucidate the role of vitamin D in complex diseases. OBJECTIVE: The objective of the study was to explore the association between seven vitamin D metabolism gene single-nucleotide polymorphisms (SNPs) and the risk of IA and progression to T1D. DESIGN: The Diabetes Autoimmunity Study in the Young is a longitudinal, observational study. SETTING: Newborn screening for human leukocyte antigen, sibling and offspring recruitment, and follow-up took place in Denver, Colorado. PARTICIPANTS: A total of 1708 children at increased genetic risk of T1D participated in the study: 148 developed IA and 62 IA-positive children progressed to T1D. MAIN OUTCOME MEASURES: IA, defined as positivity for glutamic acid decarboxylase, insulin, or IA-2 autoantibodies on two or more consecutive visits, and T1D, diagnosed by a physician, were the main outcome measures. RESULTS: The risk of IA was associated with DHCR7/NADSYN1 rs12785878 and CYP27B1 rs4646536 [hazard ratio 1.36, 95% confidence interval 1.08-1.73 (for each additional minor allele) and hazard ratio 0.59, 95% confidence interval 0.39-0.89 (for A/G compared with the A/A genotype), respectively]. None of the vitamin D SNPs typed was associated with progression to T1D in IA-positive children. Six of the seven SNPs were significantly associated with 25-hydroxyvitamin D levels. CONCLUSIONS: DHCR7/NADSYN1 rs12785878 and CYP27B1 rs4646536 may play an important role in islet autoimmunity, the preclinical phase of T1D. These findings should be replicated in larger cohorts for confirmation.
CONTEXT: Vitamin D metabolism genes have been associated with type 1 diabetes (T1D) risk; however, these genes have not been investigated for association with the preclinical phase of T1D, islet autoimmunity (IA). Studies of vitamin D metabolism genes may elucidate the role of vitamin D in complex diseases. OBJECTIVE: The objective of the study was to explore the association between seven vitamin D metabolism gene single-nucleotide polymorphisms (SNPs) and the risk of IA and progression to T1D. DESIGN: The Diabetes Autoimmunity Study in the Young is a longitudinal, observational study. SETTING: Newborn screening for human leukocyte antigen, sibling and offspring recruitment, and follow-up took place in Denver, Colorado. PARTICIPANTS: A total of 1708 children at increased genetic risk of T1D participated in the study: 148 developed IA and 62 IA-positive children progressed to T1D. MAIN OUTCOME MEASURES: IA, defined as positivity for glutamic acid decarboxylase, insulin, or IA-2 autoantibodies on two or more consecutive visits, and T1D, diagnosed by a physician, were the main outcome measures. RESULTS: The risk of IA was associated with DHCR7/NADSYN1rs12785878 and CYP27B1rs4646536 [hazard ratio 1.36, 95% confidence interval 1.08-1.73 (for each additional minor allele) and hazard ratio 0.59, 95% confidence interval 0.39-0.89 (for A/G compared with the A/A genotype), respectively]. None of the vitamin D SNPs typed was associated with progression to T1D in IA-positive children. Six of the seven SNPs were significantly associated with 25-hydroxyvitamin D levels. CONCLUSIONS:DHCR7/NADSYN1rs12785878 and CYP27B1rs4646536 may play an important role in islet autoimmunity, the preclinical phase of T1D. These findings should be replicated in larger cohorts for confirmation.
Authors: D Hunter; M De Lange; H Snieder; A J MacGregor; R Swaminathan; R V Thakker; T D Spector Journal: J Bone Miner Res Date: 2001-02 Impact factor: 6.741
Authors: I Alloza; D Otaegui; A Lopez de Lapuente; A Antigüedad; J Varadé; C Núñez; R Arroyo; E Urcelay; O Fernandez; L Leyva; M Fedetz; G Izquierdo; M Lucas; B Oliver-Martos; A Alcina; A Saiz; Y Blanco; M Comabella; X Montalban; J Olascoaga; F Matesanz; K Vandenbroeck Journal: Genes Immun Date: 2011-12-01 Impact factor: 2.676
Authors: M Simpson; H Brady; X Yin; J Seifert; K Barriga; M Hoffman; T Bugawan; A E Barón; R J Sokol; G Eisenbarth; H Erlich; M Rewers; J M Norris Journal: Diabetologia Date: 2011-08-20 Impact factor: 10.122
Authors: Jiyoung Ahn; Kai Yu; Rachael Stolzenberg-Solomon; K Claire Simon; Marjorie L McCullough; Lisa Gallicchio; Eric J Jacobs; Alberto Ascherio; Kathy Helzlsouer; Kevin B Jacobs; Qizhai Li; Stephanie J Weinstein; Mark Purdue; Jarmo Virtamo; Ronald Horst; William Wheeler; Stephen Chanock; David J Hunter; Richard B Hayes; Peter Kraft; Demetrius Albanes Journal: Hum Mol Genet Date: 2010-04-23 Impact factor: 6.150
Authors: B Frederiksen; E Liu; J Romanos; A K Steck; X Yin; M Kroehl; T E Fingerlin; H Erlich; G S Eisenbarth; M Rewers; J M Norris Journal: J Steroid Biochem Mol Biol Date: 2012-09-07 Impact factor: 4.292
Authors: M K Shea; E J Benjamin; J Dupuis; J M Massaro; P F Jacques; R B D'Agostino; J M Ordovas; C J O'Donnell; B Dawson-Hughes; R S Vasan; S L Booth Journal: Eur J Clin Nutr Date: 2007-11-21 Impact factor: 4.016
Authors: Thomas J Wang; Feng Zhang; J Brent Richards; Bryan Kestenbaum; Joyce B van Meurs; Diane Berry; Douglas P Kiel; Elizabeth A Streeten; Claes Ohlsson; Daniel L Koller; Leena Peltonen; Jason D Cooper; Paul F O'Reilly; Denise K Houston; Nicole L Glazer; Liesbeth Vandenput; Munro Peacock; Julia Shi; Fernando Rivadeneira; Mark I McCarthy; Pouta Anneli; Ian H de Boer; Massimo Mangino; Bernet Kato; Deborah J Smyth; Sarah L Booth; Paul F Jacques; Greg L Burke; Mark Goodarzi; Ching-Lung Cheung; Myles Wolf; Kenneth Rice; David Goltzman; Nick Hidiroglou; Martin Ladouceur; Nicholas J Wareham; Lynne J Hocking; Deborah Hart; Nigel K Arden; Cyrus Cooper; Suneil Malik; William D Fraser; Anna-Liisa Hartikainen; Guangju Zhai; Helen M Macdonald; Nita G Forouhi; Ruth J F Loos; David M Reid; Alan Hakim; Elaine Dennison; Yongmei Liu; Chris Power; Helen E Stevens; Laitinen Jaana; Ramachandran S Vasan; Nicole Soranzo; Jörg Bojunga; Bruce M Psaty; Mattias Lorentzon; Tatiana Foroud; Tamara B Harris; Albert Hofman; John-Olov Jansson; Jane A Cauley; Andre G Uitterlinden; Quince Gibson; Marjo-Riitta Järvelin; David Karasik; David S Siscovick; Michael J Econs; Stephen B Kritchevsky; Jose C Florez; John A Todd; Josee Dupuis; Elina Hyppönen; Timothy D Spector Journal: Lancet Date: 2010-06-10 Impact factor: 79.321
Authors: Jason D Cooper; Deborah J Smyth; Neil M Walker; Helen Stevens; Oliver S Burren; Chris Wallace; Christopher Greissl; Elizabeth Ramos-Lopez; Elina Hyppönen; David B Dunger; Timothy D Spector; Willem H Ouwehand; Thomas J Wang; Klaus Badenhoop; John A Todd Journal: Diabetes Date: 2011-03-25 Impact factor: 9.461
Authors: Giuseppe Saggese; Francesco Vierucci; Flavia Prodam; Fabio Cardinale; Irene Cetin; Elena Chiappini; Gian Luigi De' Angelis; Maddalena Massari; Emanuele Miraglia Del Giudice; Michele Miraglia Del Giudice; Diego Peroni; Luigi Terracciano; Rino Agostiniani; Domenico Careddu; Daniele Giovanni Ghiglioni; Gianni Bona; Giuseppe Di Mauro; Giovanni Corsello Journal: Ital J Pediatr Date: 2018-05-08 Impact factor: 2.638
Authors: Maija E Miettinen; Melissa C Smart; Leena Kinnunen; Christopher Mathews; Valma Harjutsalo; Heljä-Marja Surcel; Christel Lamberg-Allardt; Jaakko Tuomilehto; Graham A Hitman Journal: Diabetologia Date: 2015-06-26 Impact factor: 10.122
Authors: Bobbie-Jo M Webb-Robertson; Ernesto S Nakayasu; Brigitte I Frohnert; Lisa M Bramer; Sarah M Akers; Jill M Norris; Kendra Vehik; Anette-G Ziegler; Thomas O Metz; Stephen S Rich; Marian J Rewers Journal: J Clin Endocrinol Metab Date: 2022-07-14 Impact factor: 6.134
Authors: Patrick M Carry; Lauren A Vanderlinden; Randi K Johnson; Fran Dong; Andrea K Steck; Brigitte I Frohnert; Marian Rewers; Ivana V Yang; Katerina Kechris; Jill M Norris Journal: Pediatr Diabetes Date: 2020-02-28 Impact factor: 4.866
Authors: Colleen Elizabeth Hayes; Shane L Hubler; Jerott R Moore; Lauren E Barta; Corinne E Praska; Faye E Nashold Journal: Front Immunol Date: 2015-03-18 Impact factor: 7.561